Hvis de samme alvorlige bivirkninger forekommer igen, bør man i hvert enkelt tilfælde alvorligt overveje at tage beslutning om at stoppe behandlingen.
If the same severe adverse reactions occur for a second time, the decision to stop the treatment should be seriously considered on a case by case basis.